Compounds > citalopram

citalopram and trazodone hydrochloride

citalopram has been researched along with trazodone hydrochloride in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Doron, R; Einat, N; Kately, N; Lotan, D; Marom, I; Meron, G; Rehavi, M; Winer, A; Yaffe, R1
Burstein, O; Doron, R; Franko, M; Handelsman, A; Rehavi, M; Shamir, A; Toledano, R; Versano, Z1

Other Studies

5 other study(ies) available for citalopram and trazodone hydrochloride

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice.
    Life sciences, 2014, Jan-17, Volume: 94, Issue:2

    Topics: Animals; Brain Chemistry; Brain-Derived Neurotrophic Factor; Citalopram; Crataegus; Depression; Disease Models, Animal; Female; Hypothalamus; Lilium; Male; Mice; Mice, Inbred ICR; Phytotherapy; Plant Preparations; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sexual Behavior, Animal; Stress, Psychological; Triticum

2014
Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant Treatment.
    Journal of molecular neuroscience : MN, 2019, Volume: 69, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Citalopram; Corpus Striatum; Crataegus; Depression; Drug Evaluation, Preclinical; Hypothalamus; Lilium; Mice; Mice, Inbred ICR; Monoamine Oxidase; Nerve Tissue Proteins; Phytotherapy; Plant Preparations; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Triticum; Tyramine; Ziziphus

2019